Ambre Morley: Vetting Celebrity Spokespersons to Ensure Return on Investment
In this 2-minute audio snippet, Ambre Morley, Associate Director, Product Communications, Novo Nordisk, talks about vetting Paula Deen as a paid celebrity spokesperson for the Novo Victoza diabetes drug franchise and the importance of measuring celebrity return on investment (ROI).
Pharmaguy™’s Twitter Stream – Q2 2013
Pharmaguy™ is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News
Pharmaguy’s Twitter Stream – 2008
Pharmaguy is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News
Pharmaguy™’s Twitter Stream – Q4 2013
Pharmaguy™ is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News
Counter Detailing Offers Redemption for Pharma Sales Reps But Little Hope of Success
Do you hate your job in pharma? Perhaps, like a friend of mine, your position got eliminated after many years of loyal service. But it may be a blessing in disguise if the behavior of Big Pharma is more and more at odds with your personal values. If so, you have options for cleansing your soul.
Lea Katsanis: Benefits & Risks of Rx Brand Personality
In this 2.5-minute audio snippet, Lea Katsanis, PhD, Marketing Professor at Concordia University's John Molson School of Business, talks about Rx brand personalities as perceived by consumers and how pharmaceutical marketers can use or abuse how consumers perceive their brands' human characteristics.
Rob Helper: The Market Research Benefits of Social Video
In this 2.5-minute audio snippet, Rob Halper, former Director, Corporate Communications and Video Communication, at Johnson & Johnson, talks about the benefits of truly social video. In particular, socially-enabled Youtube videos can be valuable market research tools.
5-Minute Audio Podcasts
Pharmaguy™ is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News
Bradley Merrill Thompson: The Need for More Balanced Enforcement of Mobile Medical App Regulations
Bradley Merrill Thompson, Member of the Firm at Epstein Becker & Green and General Counsel to the mHealth Regulatory Coalition, describes a urine analysis mobile app that illustrates why the mobile health app industry needs more consistent and balanced FDA enforcement of mobile regulations.
Pharmaguy’s Twitter Stream
Pharmaguy is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News
